NCT04001712 is a Phase 3 clinical trial of Caffeine Citrate in Preterm Birth, sponsored by Ain Shams University.

Who is sponsoring NCT04001712?

NCT04001712 is sponsored by Ain Shams University.

What drugs are being tested in NCT04001712?

Interventions in NCT04001712: Caffeine Citrate.

What condition does NCT04001712 study?

NCT04001712 studies Preterm Birth.

Is NCT04001712 still recruiting?

NCT04001712 is currently completed. Last updated 2 July 2019.

Last reviewed 2019-07-02 · How we verify

NCT04001712

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Early Use of Caffeine Citrate in Preterm Neonates

Completed Phase 3 Last updated 2 July 2019

What this trial tests

Phase 3 trial testing Caffeine Citrate in Preterm Birth in 54 participants. Completed in 10 June 2019.

Timeline

5 April 2019

Primary endpoint
5 May 2019

10 June 2019

Quick facts

Lead sponsor	Ain Shams University
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	54
Start date	5 April 2019
Primary completion	5 May 2019
Estimated completion	10 June 2019
Sites	1 location across Egypt

Drugs / interventions tested

Caffeine Citrate — full drug profile →

Conditions studied

Preterm Birth — all drugs for Preterm Birth →

Sponsor

Ain Shams University

Who can join

Under 24 Hours, any sex, with Preterm Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This work is designed to study the effect of the early use of caffeine citrate in preterm neonates who need respiratory support on morbidity and short term neonatal outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Caffeine Citrate

Trials testing the same drug.

NCT07216365 — Caffeine Optimization for Oxygen Saturation Index in ELBW Infants · Phase 2 · not yet recruiting
NCT04044976 — Caffeine Treatment in in the Delivery Room · NA · completed
NCT03340727 — Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial · Phase 3 · terminated
NCT03577730 — Caffeine and Neurologic Recovery Following Surgery and General Anesthesia · EARLY_PHASE1 · completed
NCT03097900 — Does Caffeine Enhance Bowel Recovery After Colorectal Surgery? · Phase 2 · completed

Other recruiting trials for Preterm Birth

Currently open trials in the same condition.

NCT07265583 — Early Prediction of Lung Injury in Preterm Infants Score · recruiting
NCT07305935 — Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury · NA · recruiting
NCT07192393 — Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocoliti · recruiting
NCT06826859 — Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) · Phase 1, PHASE2 · recruiting
NCT07231432 — Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India · NA · active not recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04001712 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 2 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04001712.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing